Maybe this is a longtime, easily available and non-not many side effect drug.
Like HCQ, or Ivermectin.
Let’s hope so...and, that ACTUAL, real docs - not the FRAUDci/gov’t hacks - are the ones explaining it’s proven efficacy, this time.
Could be this?
“Leronlimab is a monoclonal antibody knocking on the door of an Emergency Use Authorization (EUA) from the FDA. President Trump has scheduled a press conference today to announce a “breakthrough” therapy. It has to be Leronlimab whose owner, CytoDyn (CYDY) just presented favorable data from a double blinded placebo controlled study. It is the only drug to have done so. The drug showed efficacy and safety in a difficult population to address: mild to moderate patients. So while Gilead’s (GILD) Remdesivir (the only other drug with an EUA for Covid), remains controversial, there’s an opening for something better and Leronlimab certainly is that.“